HomeInsightsMarket Capitalization

Market Capitalization of Gujarat Themis Biosyn Ltd

Market Capitalization of Gujarat Themis Biosyn Ltd

stocks purchased

₹ 2.2 Cr

Volume transacted

stocks purchased

69.4 K

stocks traded

Last Updated time: 05 Nov 12:22 PM

Image

Gujarat Themis Biosyn Ltd

NSE: GUJTHEMIS

MARKETCAP

3180.15 crore

Last updated on: Nov 04, 2024

Key Highlights

  • The Market Cap of Gujarat Themis Biosyn Ltd is ₹ 3180 crore as of 04 Nov 24.
  • The Market Cap of Gujarat Themis Biosyn Ltd changed from ₹ 57.1 crore on March 2019 to ₹ 2877 crore on March 2024 . This represents a CAGR of 92.19% over 6 years. .
  • The Latest Trading Price of Gujarat Themis Biosyn Ltd is ₹ 315.85 as of 05 Nov 12:14.

Historical Market Cap of Gujarat Themis Biosyn Ltd

No data available

* All values are in crore

Company Fundamentals for Gujarat Themis Biosyn Ltd

No data available

Image

Gujarat Themis Biosyn Ltd

NSE: GUJTHEMIS

PRICE

315.85

24.00 (8.22%)

stock direction

Last updated on: Nov 05 12:14 PM

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Gujarat Themis Biosyn Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 2024291.85
01 Nov 2024301.5
31 Oct 2024278.1
30 Oct 2024277.85
29 Oct 2024286
28 Oct 2024284.4
25 Oct 2024284.6
24 Oct 2024298.95
23 Oct 2024299.5
22 Oct 2024294.5

SWOT Analysis Of Gujarat Themis Biosyn Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Gujarat Themis Biosyn Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Gujarat Themis Biosyn Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Gujarat Themis Biosyn Ltd

No data available

Historical P/E Ratio of Gujarat Themis Biosyn Ltd

No data available

* All values are in %

Historical Revenue of Gujarat Themis Biosyn Ltd

No data available

* All values are in crore

Historical EBITDA of Gujarat Themis Biosyn Ltd

No data available

* All values are in crore

Historical Net Profit of Gujarat Themis Biosyn Ltd

No data available

* All values are in crore

Historical Dividend Payout of Gujarat Themis Biosyn Ltd

No data available

* All values are in %

About Gujarat Themis Biosyn Ltd

  • Promoted by Kantilal Shah, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985.
  • It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007. Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990.

Gujarat Themis Biosyn Ltd News Hub

News

Gujarat Themis Biosyn schedules board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 25 O...

Read more

19 Oct 202409:25

News

Gujarat Themis' Q1 PAT falls over 25% YoY to Rs 13 crore

This decline was primarily driven by a 21.7% YoY drop in net sales to Rs 38.83 crore. Tota...

Read more

27 Jul 202409:25

News

Board of Gujarat Themis Biosyn appoints director

The Board of Gujarat Themis Biosyn has approved the appointment of K. G. Ananthakrishnan (...

Read more

26 Jul 202419:50

News

Gujarat Themis Biosyn schedules board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 26 J...

Read more

17 Jul 202410:09

News

Gujarat Themis Biosyn to convene AGM

Gujarat Themis Biosyn announced that the 43th Annual General Meeting(AGM) of the company w...

Read more

14 May 202417:12

News

Board of Gujarat Themis Biosyn recommends Final Dividend

Gujarat Themis Biosyn announced that the Board of Directors of the Company at its meeting ...

Read more

14 May 202415:48

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Gujarat Themis Biosyn Ltd Market Cap

What is the market cap of Gujarat Themis Biosyn Ltd?

As of November 5, 2024, Gujarat Themis Biosyn Ltd has a market capitalization of ₹3180.15, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Gujarat Themis Biosyn Ltd's market capitalization?

Gujarat Themis Biosyn Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Gujarat Themis Biosyn Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Gujarat Themis Biosyn Ltd's market capitalization change?

Gujarat Themis Biosyn Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*